PAS
ADPT icon

Point72 Asia (Singapore)’s Adaptive Biotechnologies ADPT Stock Holding History

Point72 Asia (Singapore)’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,522
Closed -$15.1K – 841
2024
Q4 		$15.1K Buy
+2,522
New +$13.9K ﹤0.01% 698

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asia (Singapore)'s ADPT Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Adaptive Biotechnologies (ADPT) in Q1 2025, closing a stake of 2,522 shares — an estimated $15.1K sold.

Point72 Asia (Singapore) first reported a position in ADPT in Q4 2024 and held it in 1 quarter. The position peaked at $15.1K in Q4 2024. 225 funds tracked by Wall St. Rank hold ADPT as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining Adaptive Biotechnologies position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 2,522 Adaptive Biotechnologies shares in Q1 2025, an estimated $15.1K.
  • Point72 Asia (Singapore) first reported a position in Adaptive Biotechnologies in Q4 2024 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s Adaptive Biotechnologies position peaked at $15.1K in Q4 2024.
  • 225 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.